<qa>  What is the first line therapy for HER2 negative metastatic breast cancer?To explore molecular biomarkers andor gene expression signatures that predict response to bevacizumab given in combination with paclitaxel as first line therapy in HER2 negative metastatic breast cancer MBC. 